EUVIMEDEUVIMED entdecken
Crossref

Exploratory study on the synergistic use of plasma neurofilament light chain, phosphorylated Tau181, and retinal examination for assessing the risk of Alzheimer's disease and mild cognitive impairment

Xiaoxue He iD, Weiyao Liu iD, Ruijun Liu iD, Baoluo Li, Xiufeng Xu, Yuqi Cheng iD, Yan Li, Hongyan Jiang iD

Journal of Alzheimer’s Disease · 2026-07 · 112 (2) · 977-990

DOI: 10.1177/13872877261453611 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 29.05.2026. Verfasst von Xiaoxue He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, The First Affiliated Hospital of Kunming Medical University, Yunnan, China. Hauptthemen laut MEDLINE: Cognitive Dysfunction, tau Proteins, Alzheimer Disease, Neurofilament Proteins. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Academician Song Weihong Workstation in Yunnan Province, Scientific Research Project of Yunnan Provincial Clinical Medical Center, Study on the Pathological Mechanisms of Late-Life Depression and Cognitive Impairment…, Yunnan Provincial Science and Technology Plan Project - Clinical Medical Research Center Special Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Biomarker detection is crucial for diagnosing Alzheimer's disease (AD). A highly promising approach combines non-invasive fundus imaging of the retinal nerve fiber layer (RNFL) with plasma biomarkers. Combining RNFL with plasma neurofilament light chain (pNFL) and phosphorylated Tau181 (P-tau181) may play a significant role in the diagnosis and monitoring of mild cognitive impairment (MCI) and AD.

Objective

This study aimed to evaluate the utility of combining RNFL thickness with plasma pNFL and P-tau181 levels for assessing the risk of clinically diagnosed AD.

Methods

A total of 143 patients with AD and MCI underwent clinical and cognitive assessments as well as biomarker evaluations (plasma pNFL, P-tau181, RNFL), and receiver operating characteristic (ROC) analysis was finally employed to assess their diagnostic efficacy for clinically diagnosed AD.

Results

Significant inverse correlations were found between Mini-Mental State Examination scores and pNFL (R 2 = 0.344, p < 0.001) and P-tau181 (R 2 =0.424, p < 0.001). Temporal RNFL thickness was significantly lower in the MCI group versus healthy control (HCs), while the AD group showed intermediate thickness not significantly different from HCs. For AD diagnosis, pNFL achieved the highest area under the curve (AUC=0.748). Combining pNFL with P-tau181 improved the AUC to 0.784, and models further incorporating Apolipoprotein E ( APOE ) ε4 or RNFL thickness similarly showed high accuracy (AUCs=0.785/0.782).

Conclusions

Elevated levels of pNFL and P-tau181 are independent risk factors for cognitive decline. Combination with fundus examination confers significant diagnostic utility for clinically diagnosed AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive Dysfunctiontau ProteinsAlzheimer DiseaseNeurofilament ProteinsRetinaHumansFemaleMalePhosphorylationBiomarkersAgedROC Curve

Stichwörter der Autor:innen

Alzheimer's diseasemild cognitive impairmentplasma nerve filament light chainsplasma phosphorylated Tau181 proteinretinal nerve fiber layer

Substanzen

tau ProteinsNeurofilament ProteinsBiomarkersneurofilament protein LMAPT protein, human

Autor:innen und Institutionen

  • Department of Psychiatry, The First Affiliated Hospital of Kunming Medical University, Yunnan, China.
  • Ophthalmology, The First Affiliated Hospital of Kunming Medical University, Yunnan, China.

ORCID-Profile: Xiaoxue He, Weiyao Liu, Ruijun Liu, Yuqi Cheng, Hongyan Jiang

Förderung

  • Academician Song Weihong Workstation in Yunnan Province
  • Scientific Research Project of Yunnan Provincial Clinical Medical Center, Study on the Pathological Mechanisms of Late-Life Depression and Cognitive Impairment…
  • Yunnan Provincial Science and Technology Plan Project - Clinical Medical Research Center Special Program

Zitieren

APA

He, X., Liu, W., Liu, R., Li, B., Xu, X., Cheng, Y., Li, Y., & Jiang, H. (2026). Exploratory study on the synergistic use of plasma neurofilament light chain, phosphorylated Tau181, and retinal examination for assessing the risk of Alzheimer's disease and mild cognitive impairment. Journal of Alzheimer’s Disease, 112(2), 977-990. https://doi.org/10.1177/13872877261453611

Vancouver

He X, Liu W, Liu R, Li B, Xu X, Cheng Y, et al. Exploratory study on the synergistic use of plasma neurofilament light chain, phosphorylated Tau181, and retinal examination for assessing the risk of Alzheimer's disease and mild cognitive impairment. Journal of Alzheimer’s Disease. 2026;112(2):977-990. doi:10.1177/13872877261453611

BibTeX
@article{He2026,
  author = {He, Xiaoxue and Liu, Weiyao and Liu, Ruijun and Li, Baoluo and Xu, Xiufeng and Cheng, Yuqi and Li, Yan and Jiang, Hongyan},
  title = {Exploratory study on the synergistic use of plasma neurofilament light chain, phosphorylated Tau181, and retinal examination for assessing the risk of Alzheimer's disease and mild cognitive impairment},
  journal = {Journal of Alzheimer’s Disease},
  year = {2026},
  volume = {112},
  number = {2},
  pages = {977--990},
  doi = {10.1177/13872877261453611}
}
Kostenlos starten →